Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kerry Medicare Rx "Overhaul" May Include PBMs To Negotiate On Behalf Of HHS

This article was originally published in The Pink Sheet Daily

Executive Summary

Democratic presidential candidate wants to find a way to use federal government's bulk purchasing leverage through private contractors to conduct genuine "negotiations" for drugs – not set prices, staffer says.

You may also be interested in...



Medicare Rx Course Is Clearer Following Bush Victory

President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare

Medicare Rx Course Is Clearer Following Bush Victory

President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare

Democratic Candidate Kerry On Rx Pricing: Canada Can Do Better

Acceptance speech includes call for reimportation and repeal of "non-interference" clause under Medicare Rx. Kerry also offers hopeful vision for potential of biomedical research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS060232

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel